Are GLP-1 Medications HSA/FSA Eligible?
A GLP-1 can run hundreds of dollars a month out of pocket, so paying with pre-tax HSA or FSA dollars is effectively a 20-37% discount depending on your tax bracket. The catch is a single IRS rule that decides whether your specific situation qualifies. Here is exactly how it works in July 2026.
The one rule that decides eligibility (IRS Publication 502)
The IRS treats weight-loss treatment as a qualified medical expense only when it treats a specific disease diagnosed by a physician - the examples the IRS itself names are obesity, hypertension, and heart disease. The same publication is explicit about what does notqualify: any weight-loss expense whose purpose is “the improvement of appearance, general health, or sense of well-being.”
Every HSA and FSA administrator applies that same test, because it comes directly from IRS Publication 502. So the question is never “is Wegovy on the eligible list?” - it is “is my Wegovy prescription tied to a diagnosed condition?”
Eligibility by situation
| Your situation | Typical drug | Eligible? |
|---|---|---|
| Type 2 diabetes | Ozempic, Mounjaro | Yes |
| Obesity (BMI 30+) | Wegovy, Zepbound | Yes |
| Overweight (BMI 27+) with a comorbidity | Wegovy, Zepbound | Yes |
| Compounded semaglutide/tirzepatide | Telehealth compounded | Often denied |
| Cosmetic / general wellness weight loss | Any GLP-1 | No |
BMI thresholds mirror the FDA labeling for the weight-loss GLP-1s and the standard obesity / overweight-with-comorbidity criteria administrators look for. Your administrator's documentation requirements can be stricter than the IRS minimum.
The Letter of Medical Necessity (LMN)
An LMN is a short signed letter from your prescriber. For a weight-loss GLP-1 it is the single most useful document to have, because it converts “a weight-loss drug” (which triggers scrutiny) into “a treatment for a diagnosed disease” (which is clearly eligible). A complete LMN states:
- Your diagnosis (e.g. obesity, or overweight with a named comorbidity)
- The specific medication prescribed
- The clinical reason the medication is medically necessary for that condition
- The expected duration of treatment
How to get one: message or call your prescribing provider, say you are paying with an HSA or FSA and need a Letter of Medical Necessity for your GLP-1. Most providers handle this request routinely and turn it around quickly. Keep it with your tax records - you generally will not submit it unless a claim is questioned or the account is audited.
HSA vs FSA, and the 2026 limits
HSA
- Yours permanently; balance rolls over and follows you between jobs
- Requires a high-deductible health plan
- 2026 limit: $4,400 self-only / $8,750 family
- Extra $1,000 catch-up contribution at age 55+
- Best fit for a year-round GLP-1 expense
FSA
- Employer-owned; generally use-it-or-lose-it within the plan year
- Some plans allow a small carryover or grace period
- 2026 limit: $3,400
- No high-deductible-plan requirement
- Works fine for a GLP-1 if you plan the annual spend
2026 figures per IRS Revenue Procedure 2025-19 (HSA) and the 2026 FSA salary-reduction limit. Contribution limits are indexed annually - confirm the current year's numbers with your plan administrator.
Employer coverage and lifestyle spending accounts
Separately from your HSA/FSA, your employer may help with GLP-1 costs in one of two ways. Some cover the drug through the health plan directly - per Mercer's 2026 survey work, about 49% of large employers (500+ employees) covered GLP-1 weight-loss medications in 2025, up from 44% the year before, though a small share have begun dropping that coverage as costs climb.
Others offer a lifestyle spending account (LSA)or wellness stipend you can apply toward health expenses including GLP-1s. Compt's 2026 Lifestyle Benefits Benchmark Report put the median per-employee wellness stipend at about $735 for 2025, with all-inclusive LSAs the most common structure (offered by 64% of the companies surveyed). If your employer offers one, it stacks on top of - it does not replace - your pre-tax HSA/FSA eligibility.
Frequently asked questions
Are GLP-1 medications HSA and FSA eligible?
Yes, when they are prescribed to treat a specific condition diagnosed by a physician - obesity, type 2 diabetes, or being overweight (BMI 27+) with a comorbidity such as high blood pressure, high cholesterol, or obstructive sleep apnea. What is NOT eligible is a GLP-1 taken purely to improve appearance, general health, or sense of well-being. That distinction comes straight from IRS Publication 502, which is the rule every HSA and FSA administrator applies.
Do I need a Letter of Medical Necessity for Wegovy or Zepbound?
For a weight-loss-only prescription, yes - or at least you should have one on file. Wegovy and Zepbound are weight-management drugs, so administrators scrutinize them more than, say, insulin. A Letter of Medical Necessity (LMN) from your prescriber states your diagnosis, why the medication is medically necessary, and the expected duration of treatment. Even if your plan does not demand it up front, having the LMN on file protects your reimbursement if the account is ever audited. Ozempic or Mounjaro prescribed for type 2 diabetes usually clears without an LMN because the diagnosis is unambiguous.
Can I use my HSA or FSA for compounded semaglutide or telehealth GLP-1s?
Sometimes, but expect more friction. Many HSA/FSA administrators apply stricter scrutiny to compounded medications and can reject the claim - particularly for an obesity indication - so confirm with your specific administrator before assuming a compounded semaglutide order is reimbursable. Telehealth-prescribed branded GLP-1s follow the same rule as any other: valid prescription, qualifying diagnosis, and a receipt showing the drug name, date, and cost. Keep the prescriber's diagnosis documentation in case the claim is questioned.
What is the difference between using an HSA vs an FSA for this?
Both let you pay with pre-tax dollars, but the mechanics differ. An HSA is yours permanently, the balance rolls over every year and follows you between jobs, and in 2026 you can contribute up to $4,400 (self-only) or $8,750 (family), plus a $1,000 catch-up at age 55+. It requires a high-deductible health plan. An FSA is employer-owned, generally use-it-or-lose-it within the plan year (some plans allow a small carryover or grace period), and the 2026 contribution cap is $3,400. For a year-round GLP-1 expense, an HSA's rollover is the friendlier structure, but an FSA still works fine if you plan the spend.
Does my employer have to cover the GLP-1 for me to use my HSA/FSA?
No - these are two separate things. Your HSA/FSA eligibility depends on the IRS rule (a qualifying diagnosis), not on whether your health plan covers the drug. So even if your insurance denies Wegovy, you can still pay for it out of pocket with pre-tax HSA or FSA dollars as long as it treats a diagnosed condition. Some employers separately offer GLP-1 coverage or a lifestyle spending account you can apply toward the medication, but that is a bonus, not a requirement for pre-tax eligibility.
How do I actually pay - card at the pharmacy, or reimburse myself later?
Either. The simplest path is to use your HSA or FSA debit card directly at the pharmacy. If the card is declined (some administrators block weight-loss drug codes at point of sale), pay with a regular card, keep the itemized pharmacy receipt, and submit it for reimbursement along with your Letter of Medical Necessity if you have one. Most reimbursement claims process within a couple of business days once documentation is verified.
Related guides
Stay ahead of every GLP-1 development
We'll email you when something actually matters: new FDA approvals (Foundayo, CagriSema, retatrutide), pricing drops at LillyDirect/NovoCare, telehealth deals, clinical trial results, FDA recalls, and insurance policy changes. ~1-2 emails/month. No filler.
This page is educational and not tax or legal advice. HSA/FSA rules are applied by your plan administrator and can be stricter than the IRS minimum; confirm your specific situation with your administrator or a tax professional.